Company & Sponsor Intelligence

Singapore General Hospital

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting0

Completed2

Countries1

Therapeutic footprint

other_neurologypain_neuropathystroke

Indexed studies

NCT00669344RIVastigmine In Vascular cognitivE Impairment
stroke · SingaporePHASE4

NCT01093872Repetitive Transcranial Magnetic Stimulation for Tinnitus Treatment
other_neurology · SingaporeNA

NCT01061697Pregabalin and Radicular Pain Study (PARPS)
pain_neuropathy · SingaporePHASE4

Intelligence layer updated: 2026-11-03 06:12:30.767591+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →